Magnus Johansson, professor of biomedicine, runs the project together with Sören Andersson, professor of medicine, and Åke Strid, professor of biochemistry. They have recently received 14 million to develop their ideas.

Syringes more risky

Vaccines that are taken up by the mucous membranes already exist, but Örebro researchers believe that there is great development potential.

- It is through the mucous membranes that many viruses and bacteria enter the body and this is where most of our immune system already exists. So therefore it is advisable to give vaccine the same way.

- In addition, it is more risky and complicated with vaccine in syringes, than if you can take it as a spray in the nose or a tablet, says Magnus Johansson.

Then you can start testing

Within four years, the research trio hopes to have gone so far as to be able to start testing the new vaccines on humans.